JP2015506347A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506347A5
JP2015506347A5 JP2014548899A JP2014548899A JP2015506347A5 JP 2015506347 A5 JP2015506347 A5 JP 2015506347A5 JP 2014548899 A JP2014548899 A JP 2014548899A JP 2014548899 A JP2014548899 A JP 2014548899A JP 2015506347 A5 JP2015506347 A5 JP 2015506347A5
Authority
JP
Japan
Prior art keywords
optionally substituted
nitrogen
membered
oxygen
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014548899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015506347A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/070980 external-priority patent/WO2013096637A1/en
Publication of JP2015506347A publication Critical patent/JP2015506347A/ja
Publication of JP2015506347A5 publication Critical patent/JP2015506347A5/ja
Pending legal-status Critical Current

Links

JP2014548899A 2011-12-23 2012-12-20 ヘテロアリールおよびその使用 Pending JP2015506347A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161579711P 2011-12-23 2011-12-23
US61/579,711 2011-12-23
US201261672030P 2012-07-16 2012-07-16
US61/672,030 2012-07-16
US201261716172P 2012-10-19 2012-10-19
US61/716,172 2012-10-19
PCT/US2012/070980 WO2013096637A1 (en) 2011-12-23 2012-12-20 Heteroaryls and uses thereof

Publications (2)

Publication Number Publication Date
JP2015506347A JP2015506347A (ja) 2015-03-02
JP2015506347A5 true JP2015506347A5 (enExample) 2016-02-18

Family

ID=48655164

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014548896A Pending JP2015503504A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548902A Pending JP2015503505A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548899A Pending JP2015506347A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2014548896A Pending JP2015503504A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548902A Pending JP2015503505A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用

Country Status (7)

Country Link
US (3) US20130165464A1 (enExample)
EP (3) EP2793894A4 (enExample)
JP (3) JP2015503504A (enExample)
AR (3) AR089445A1 (enExample)
TW (3) TW201332989A (enExample)
UY (3) UY34538A (enExample)
WO (3) WO2013096630A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2010090716A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201217365A (en) 2010-08-11 2012-05-01 Millennium Pharm Inc Heteroaryls and uses thereof
TW201307309A (zh) 2010-10-13 2013-02-16 Millennium Pharm Inc 雜芳基化合物及其用途
SI3038622T1 (en) 2013-08-28 2018-08-31 Medivation Technologies Llc Heterocyclic compounds and methods of use
WO2015108881A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2015108861A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
CN106922146B (zh) * 2014-10-02 2020-05-26 豪夫迈·罗氏有限公司 用于治疗由布鲁顿酪氨酸激酶(btk)介导的疾病的吡唑甲酰胺化合物
EP3265457A1 (en) 2015-03-04 2018-01-10 Medivation Technologies LLC Sterol regulatory element-binding proteins (srebps) inhibitors
US10183015B2 (en) 2015-03-04 2019-01-22 Medivation Technologies Llc Heterocyclic compounds and methods of use
JP2019513700A (ja) 2016-03-16 2019-05-30 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 殺有害生物剤及び植物保護剤としてのn−(シアノベンジル)−6−(シクロプロピル−カルボニルアミノ)−4−(フェニル)−ピリジン−2−カルボキサミド誘導体及び関連する化合物
EP3284739A1 (de) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituierte (het)arylverbindungen als schädlingsbekämpfungsmittel
MY201038A (en) * 2017-07-28 2024-01-31 Yuhan Corp Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same
SG11201913517UA (en) 2017-07-28 2020-02-27 Yuhan Corp Improved process for preparing aminopyrimidine derivatives
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN110041252A (zh) * 2019-05-22 2019-07-23 南京合巨药业有限公司 一种2-氯-4-肼基吡啶的制备方法
CN114867724B (zh) * 2019-05-31 2025-11-07 班塔姆制药有限责任公司 用于制备噻唑基吡唑甲酸及其中间体的方法
WO2021011720A2 (en) * 2019-07-18 2021-01-21 Avidence Therapeutics, Inc. Anti-osteoarthritis compounds and related compositions and methods
WO2025117722A1 (en) * 2023-11-27 2025-06-05 Rubedo Life Sciences, Inc. Carbon linked bcl inhibitors and senolytic compounds and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
GB2306108A (en) * 1995-10-13 1997-04-30 Merck & Co Inc Treatment of Raf-mediated cancers with imidazole derivatives
IL136768A0 (en) * 1997-12-22 2001-06-14 Bayer Ag INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
WO2002092573A2 (en) * 2001-05-16 2002-11-21 Vertex Pharmaceuticals Incorporated Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
EP1414443B1 (en) * 2001-08-01 2006-11-15 Merck & Co., Inc. BENZIMIDAZO 4,5-f|ISOQUINOLINONE DERIVATIVES
US7582631B2 (en) * 2004-01-14 2009-09-01 Amgen Inc. Substituted heterocyclic compounds and methods of use
CA2589827A1 (en) * 2004-12-21 2006-06-29 Merck & Co., Inc. Mitotic kinesin inhibitors
MX2007008781A (es) * 2005-01-21 2007-09-11 Astex Therapeutics Ltd Compuestos farmaceuticos.
AU2007275221A1 (en) * 2006-07-20 2008-01-24 Allen J. Borchardt Benzothiophene inhibitors of RHO kinase
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
EP2134175A4 (en) * 2007-03-29 2012-01-11 Glaxosmithkline Llc HAMMER OF ACT ACTIVITY
GB0709031D0 (en) * 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
TW200911798A (en) * 2007-08-02 2009-03-16 Amgen Inc PI3 kinase modulators and methods of use
WO2009115572A2 (en) * 2008-03-21 2009-09-24 Novartis Ag Novel heterocyclic compounds and uses therof
ES2491522T3 (es) * 2008-06-19 2014-09-08 Millennium Pharmaceuticals, Inc. Derivados de tiofeno o tiazol y su uso como inhibidores de PI3K
US9187426B2 (en) * 2008-06-27 2015-11-17 Novartis Ag Organic compounds
WO2010090716A1 (en) * 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
WO2010127152A2 (en) * 2009-04-29 2010-11-04 Irm Llc Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
EP2430013B1 (en) * 2009-05-13 2014-10-15 Amgen Inc. Heteroaryl compounds as pikk inhibitors
AR077975A1 (es) * 2009-08-28 2011-10-05 Irm Llc Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
WO2011149874A2 (en) * 2010-05-26 2011-12-01 Schering Corporation N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
WO2012084678A1 (en) * 2010-12-23 2012-06-28 Syngenta Participations Ag Novel imidazoles useful as plant fungicides
US9090628B2 (en) * 2011-03-21 2015-07-28 Genentech, Inc. Benzoxazepin compounds selective for PI3K P110 delta and methods of use
US9732085B2 (en) * 2011-12-21 2017-08-15 Ono Pharmaceutical Co., Ltd. Pyridinone and pyrimidinone derivatives as factor Xia

Similar Documents

Publication Publication Date Title
JP2015506347A5 (enExample)
JP2015503505A5 (enExample)
JP2015503504A5 (enExample)
JP2011510080A5 (enExample)
CN110240596B (zh) 用于治疗hbv感染的治疗剂
TWI287004B (en) A pyridone derivative having an affinity effect for cannabinoid 2 type receptor
CA2563895C (en) Disalt inhibitors of il-12 production
CN104955456B (zh) 作为分拣蛋白抑制剂的n-取代的-5-取代的邻氨甲酰苯甲酸
TWI457337B (zh) 呋呫基苯并咪唑
JP2014512406A5 (enExample)
JP2008513508A5 (enExample)
JP2013533318A5 (enExample)
ES2824801T3 (es) Sal de compuesto heterocíclico sustituido con halógeno
CN101981008A (zh) 5,6-二芳基-吡啶-2-甲酰胺衍生物、其制备方法和其作为硬骨鱼紧张肽ⅱ受体拮抗剂的治疗用途
JP2023504143A (ja) セレブロンに結合するピペリジン-2,6-ジオン誘導体、及びその使用方法
JP6666458B2 (ja) 置換のアミノ6員窒素含有複素環式化合物およびその製造と使用
AU2006267454A2 (en) Benzoimidazole compound capable of inhibiting prostaglandin D synthetase
JP2016508152A (ja) Cracチャネル阻害薬としての、ピラゾリルをベースとするカルボキサミド類i
WO2008152094A2 (en) Substituted acetamides as modulators of the ep2 receptor
JP2016513726A (ja) がん細胞成長阻害剤としてのテトラヒドロイソキノリン−2−イル−(キナゾリン−4−イル)メタノン化合物
CN104334528A (zh) (2-杂芳基氨基)琥珀酸衍生物
WO2008058449A1 (fr) Dérivés de pyrroline-2-one utilisés contre le facteur de nécrose tumorale à libération cellulaire, procédés de préparation et utilisations de ceux-ci
KR20150103752A (ko) Crac 채널 억제제로서의 피라졸릴계 카복스아미드 ⅱ
JP2008088107A (ja) 新規ピリダジン誘導体
WO2017198179A1 (zh) 新型噻唑类衍生物在治疗炎性肠病中的应用